Publicaciones científicas
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis
Yiliam Fundora 1 , Amelia J Hessheimer 2 , Luca Del Prete 3 , Lorenzo Maroni 4 , Jacopo Lanari 5 , Oriana Barrios 6 , Mathias Clarysse 7 , Mikel Gastaca 8 , Manuel Barrera Gómez 9 , Agnès Bonadona 10 , Julius Janek 11 , Andrea Boscà 12 , Jose María Álamo Martínez 13 , Gabriel Zozaya 14 , Dolores López Garnica 15 , Paolo Magistri 16 , Francisco León 17 , Giulia Magini 18 , Damiano Patrono 19 , Jiří Ničovský 20 , Abdul Rahman Hakeem 21 , Silvio Nadalin 22 , Lucas McCormack 23 , Pilar Palacios 24 , Krzysztof Zieniewicz 25 , Gerardo Blanco 26 , Javier Nuño 27 , Baltasar Pérez Saborido 28 , Juan Echeverri 29 , J Steve Bynon 30 , Paulo N Martins 31 , Víctor López López 32 , Murat Dayangac 33 , J Peter A Lodge 21 , Renato Romagnoli 19 , Christian Toso 34 , Julio Santoyo 17 , Fabrizio Di Benedetto 16 , Concepción Gómez-Gavara 15 , Fernando Rotellar 14 , Miguel Ángel Gómez-Bravo 13 , Rafael López Andújar 12 , Edouard Girard 10 , Andrés Valdivieso 8 , Jacques Pirenne 7 , Laura Lladó 6 , Giacomo Germani 35 , Matteo Cescon 4 , Koji Hashimoto 3 , Cristiano Quintini 3 , Umberto Cillo 5 , Wojciech G Polak 36 , Constantino Fondevila 37
Background: Complex portal vein thrombosis (PVT) is a challenge in liver transplantation (LT). Extra-anatomical approaches to portal revascularization, including renoportal (RPA), left gastric vein (LGA), pericholedochal vein (PCA), and cavoportal (CPA) anastomoses, have been described in case reports and series. The RP4LT Collaborative was created to record cases of alternative portal revascularization performed for complex PVT.
Methods: An international, observational web registry was launched in 2020. Cases of complex PVT undergoing first LT performed with RPA, LGA, PCA, or CPA were recorded and updated through 12/2021.
Results: 140 cases were available for analysis: 74 RPA, 18 LGA, 20 PCA, and 28 CPA. Transplants were primarily performed with whole livers (98%) in recipients with median age 58 years [25-75% interquartile range 49-63], MELD 17 [14-24], and cold ischemia 431 minutes [360-505]. Post-operatively, 49% of recipients developed acute kidney injury (AKI), 16% diuretic-responsive ascites, 9% refractory ascites (29% with CPA, P<0.001), and 10% variceal hemorrhage (25% with CPA, P=0.002). After median follow-up of 22 months [4-67], patient and graft 1-/3-/5-year survival rates were 71%/67%/61% and 69%/63%/57%, respectively. On multivariate Cox proportional hazards analysis, the only factor significantly and independently associated with all-cause graft loss was non-physiological portal vein reconstruction in which all graft portal inflow arose from recipient systemic circulation (HR 6.639, 95% CI 2.159-20.422, P=0.001).
Conclusions: Alternative forms of portal vein anastomosis achieving physiological portal inflow (i.e., deriving at least some splanchnic blood to the transplant graft) offer acceptable post-transplant results in LT candidates with complex PVT. On the contrary, non-physiological portal vein anastomoses fail to resolve portal hypertension and should not be performed.
Impact and implications: Complex portal vein thrombosis (PVT) is a challenge in liver transplantation. Results of this international, multicenter analysis may be used to guide clinical decisions in transplant candidates with complex PVT. Extra-anatomical portal vein anastomoses deriving at least some recipient splanchnic blood flow to the transplant allograft offer acceptable results. On the other hand, anastomoses that derive only systemic blood flow to the allograft fail to resolve portal hypertension and should not be performed.
CITA DEL ARTÍCULO J Hepatol. 2023 Jan 20;S0168-8278(23)00018-1. doi: 10.1016/j.jhep.2023.01.007